质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
Product photo — to be added
Rx
肿瘤学 & 血液学

ALIMOBOTINIB

莫博赛替尼 (Mobocertinib)
Generic (INN)
莫博赛替尼 (Mobocertinib)
Strength
40 mg
Packaging
120粒/瓶。
Indication
Mobocertinib 是一种激酶抑制剂，适用于治疗在接受含铂化疗期间或之后疾病进展的、伴有表皮生长因子受体 (EGFR) 20 号外显子插入突变的局部晚期或转移性非小细胞肺癌 (NSCLC) 成人患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIENSIDIPINE
ALIENSIDIPINE
恩西地平 (Enasidenib)
ALIPRATINIB
ALIPRATINIB
普拉替尼 (Pralsetinib)
ALISERPATINIB
ALISERPATINIB
赛普替尼 (Selpercatinib)
OSIMITIB
OSIMITIB
奥希替尼 (Osimertinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文